MR Number;Product Name;Domain;Active substances;Pharmaceutical Form;Application Type Level 1;Application Type Level 2;Application Type Level 3;Application Type Level 4;Application Type Level 5;Marketing Authorization Holder;RMS;CMS;Date of outcome;Date of last update;ATC-Code;Strength;SPC Url;Par Url;Final Labelling Url;Final PL Url;Finalised Product Information Url
NL/H/1262/002 ;Mirtazapine Bluefish 30 mg;Human;mirtazapine  30 mg;Orodispersible tablet;Abridged;Additional Strength/Form;Generic;Chemical Substance;Prescription Only;Bluefish Pharmaceuticals AB Birger Jarlsgatan 37, 111 45,  Stockholm Sweden;Netherlands;"AT - Mirtazapin Bluefish 30 mg Schmelztabletten, CZ - Mirtazapin Bluefish 30 mg tablety dispergovatelne v ustech, DE - Mirtazapin Bluefish 30 mg Orodispersible tablets, DK - Mirtazapin ""Bluefish"", EL, ES, FI, FR, HU - Mirtazapin Bluefish szájban diszp. tabletta, IE, IT, NO, PL - Mirtazapina Bluefish, PT, RO - Mirtazapin Bluefish 30 mg comprimate orodispersabile, SE - Mirtazapin Bluefish, SK - Mirtazapine Bluefish 30 mg orodispergovateľné tablety, UK";26.02.2008;26.03.2013;N06AX11-Mirtazapine;30mg;;http://db.cbg-meb.nl/mri/par/nlh-1262-001-002-003.pdf;;;